Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
All content for Richard Helppie's Common Bridge is the property of Richard Helppie and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
Episode 281- Medicare Disadvantage: Nate Kaufman and Rich Helppie Pt. 2
Richard Helppie's Common Bridge
12 minutes
2 months ago
Episode 281- Medicare Disadvantage: Nate Kaufman and Rich Helppie Pt. 2
Are you getting what you pay for with your Medicare plan? This eye-opening conversation between healthcare insiders Nathan Kaufman and Rich Helppie pulls back the curtain on what they provocatively call "Medicare Disadvantage" plans. When something sounds too good to be true, it usually is. Medicare Advantage plans tempt seniors with zero premiums, dental coverage, vision benefits, and even gym memberships. But these apparent perks mask a troubling reality: significantly restricted healthcar...
Richard Helppie's Common Bridge
Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
